ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MDAS (MM)

31.35
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
(MM) NASDAQ:MDAS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 31.35 0 01:00:00

Post-effective Amendment to an S-8 Filing (s-8 Pos)

27/01/2016 4:52pm

Edgar (US Regulatory)


As filed with the Securities and Exchange Commission on January 27, 2016

Registration No. 333-191537

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

MedAssets, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   51-0391128
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

200 North Point Center East, Suite 600

Alpharetta, Georgia 30022

(678) 323-2500

(Address, including Zip Code, of Principal Executive Offices)

 

 

Long Term Performance Incentive Plan

(Full Title of the Plan)

Jonathan H. Glenn

Executive Vice President, Chief Legal Officer and Corporate Secretary

200 North Point Center East, Suite 600

Alpharetta, Georgia 30022

(678) 323-2500

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copy to:

Peter Martelli, Esq.

Simpson Thacher & Bartlett LLP

425 Lexington Avenue

New York, New York 10017

(212) 455-2000

 

 

 


DEREGISTRATION OF SECURITIES

This Post-Effective Amendment No. 1 relates to the Registration Statement on Form S-8 (File No. 333-191537) (the “Registration Statement”) of MedAssets, Inc., a Delaware corporation (the “Company”), which was filed with the Securities and Exchange Commission on October 2, 2013.

On January 27, 2016, pursuant to the terms of the Agreement and Plan of Merger, dated as of November 1, 2015, among the Company, Magnitude Parent Holdings, LLC, a Delaware limited liability company (“Parent”), and Magnitude Acquisition Corp., a Delaware corporation and an indirect wholly-owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Company (the “Merger”), with the Company continuing as the surviving company in the Merger.

As a result of the Merger, any and all offerings of securities registered pursuant to the Registration Statement have been terminated. In accordance with undertakings made by the Company in the Registration Statement to remove from registration, by means of a post-effective amendment, any of the securities registered under the Registration Statement that remain unsold at the termination of the offering, the Company hereby removes from registration all securities registered under the Registration Statement but unsold as of the date hereof.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, and Rule 478 thereunder, the Registrant has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Alpharetta, State of Georgia, on January 27, 2016.

 

MEDASSETS, INC.
By:  

/s/ Jonathan H. Glenn

Name:   Jonathan H. Glenn
Title:   Executive Vice President, Chief Legal Officer and Corporate Secretary

1 Year (MM) Chart

1 Year (MM) Chart

1 Month (MM) Chart

1 Month (MM) Chart

Your Recent History

Delayed Upgrade Clock